Mature glycoprotein G presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different Tanzanian cohorts

Clinical and Vaccine Immunology

Volumn 13, Issue 6, 2006, Pages 633-639

  Görander, Staffan ^a   Mbwana, Judica ^a,b   Lyamuya, Eligius ^b   Lagergård, Teresa ^a   Liljeqvist, Jan Åke ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED PROTEIN; IMMUNOGLOBULIN M ANTIBODY; THROMBOSPONDIN;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL ULCER; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE; TANZANIA; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGE FACTORS; ANIMALS; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CELLS, CULTURED; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; INFECTION; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; TANZANIA; VIRAL ENVELOPE PROTEINS;

EID: 33745930536     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00051-06     Document Type: Article

References (36)

1. Ahmed, H. J., J. Mbwana, E. Gunnarsson, K. Ahlman, C. Guerino, L. A. Svensson, F. Mhalu, and T. Lagergard. 2003. Etiology of genital ulcer disease and association with human immunodeficiency virus infection in two Tanzanian cities. Sex. Transm. Dis. 30:114-119.
2. Ashley, R. L. 2002. Performance and use of HSV type-specific serology test kits. Herpes 9:38-45.
3. Ashley, R. L., J. Militoni, F. Lee, A. Nahmias, and L. Corey. 1988. Comparison of Western blot (immunoblot) and glycoprotein O-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J. Clin. Microbiol. 26:662-667.
4. Ashley, R. L., L. Wu, J. W. Pickering, M.-C. Tu, and L. Schnorenberg. 1998. Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J. Clin. Microbiol. 36:294-295.
5. Ashley-Morrow, R., E. Krantz, and A. Wald. 2003. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex. Transm. Dis. 30:310-314.
6. Ashley-Morrow, R., J. Nollkamper, N. J. Robinson, N. Bishop, and J. Smith. 2004. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin. Microbiol. Infect. 10:530-536.
7. Balachandran, N., and L. M. Hutt-Fletcher. 1985. Synthesis and processing of glycoprotein gG of herpes simplex virus type 2. J. Virol. 54:825-832.
8. Chen, C. Y., R. C. Ballard, C. M. Beck-Sague, Y. Dangor, F. Radebe, S. Schmid, J. B. Weiss, V. Tshabalala, G. Fehler, Y. Htun, and S. A. Morse. 2000. Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex. Transm. Dis. 27:21-29.
9. Eis-Hübinger, A. M., M. Däumer, B. Matz, and K. E. Schneweis. 1999. Evaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera. J. Clin. Microbiol. 37:1242-1246.
10. Golden, M. R., R. Ashley-Morrow, P. Swenson, W. R. Hogrefe, H. H. Handsfield, and A. Wald. 2005. Herpes simplex virus type 2 (HSV-2) Western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in a sexually transmitted disease clinic. Sex. Transm. Dis. 32:771-777.
11. Görander, S., B. Svennerholm, and J. Å. Liljeqvist. 2003. Secreted portion of glycoprotein G of herpes simplex virus type 2 is a novel antigen for type-discriminating serology. J. Clin. Microbiol. 41:3681-3686.
12. Ho, D. W., P. R. Field, E. Sjogren-Jansson, S. Jeansson, and A. L. Cunningham. 1992. Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J. Virol. Methods 36:249-264.
13. Hogrefe, W., X. Su, J. Song, R. Ashley, and L. Kong. 2002. Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition. J. Clin. Microbiol. 40:3635-3640.
14. Jeansson, S., and L. Molin. 1974. On the occurrence of genital herpes simplex virus infection. Clinical and virological findings and relation to gonorrhoea. Acta Dermato-Venereol. 54:479-485.
15. Laeyendecker, O., C. Henson, R. H. Gray, R. H.-N. Nguyen, B. J. Horne, M. J. Wawer, D. Serwadda, N. Kiwanuka, R. A. Morrow, W. Hogrefe, and T. C. Quinn. 2004. Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans. J. Clin. Microbiol. 42:1794-1796.
16. Langeland, N., L. Haarr, and F. Mhalu. 1998. Prevalence of HSV-2 antibodies among STD clinic patients in Tanzania. Int. J. STD AIDS 9:104-107.
17. Lee, F. K., R. M. Coleman, L. Pereira, P. D. Bailey, M. Tatsuno, and A. J. Nahmias. 1985. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J. Clin. Microbiol. 22:641-644.
18. Liljeqvist, J. A., E. Trybala, J. Hoebeke, B. Svennerholm, and T. Bergstrom. 2002. Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. J. Gen. Virol. 83:157-165.
19. Liljeqvist, J.-Å. 2000. Thesis. Göteborg University, Göteborg, Sweden.
20. Liljeqvist, J.-Å., E. Trybala, B. Svennerholm, S. Jeansson, E. Sjögren-Jansson, and T. Bergström. 1998. Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. J. Gen. Virol. 79:1215-1224.
21. Morrow, R. A., D. Friedrich, and E. Krantz. 2003. Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes. J. Clin. Microbiol. 41:5212-5214.
22. Mwansasu, A., D. Mwakagile, L. Haarr, and N. Langeland. 2002. Detection of HSV-2 in genital ulcers from STD patients in Dar es Salaam, Tanzania. J. Clin. Virol. 24:183-192.
23. Nahmias, A. J., F. K. Lee, and S. Beckman-Nahmias. 1990. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand. J. Infect. Dis. Suppl. 69:19-36.
24. Nilsen, A., D. Mwakagile, H. Marsden, N. Langeland, R. Matre, and L. Haarr. 2005. Prevalence of, and risk factors for, HSV-2 antibodies in sexually transmitted disease patients, healthy pregnant females, blood donors and medical students in Tanzania and Norway. Epidemiol. Infect. 133:915-925.
25. Riedner, G., M. Rusizoka, O. Hoffmann, F. Nichombe, E. Lyamuya, D. Mmbando, L. Maboko, P. Hay, J. Todd, R. Haves, M. Hoelscher, and H. Grosskurth. 2003. Baseline survey of sexually transmitted infections in a cohort of female bar workers in Mbeya Region, Tanzania. Sex. Transm. Infect. 79:382-387.
26. Serwadda, D., R. H. Gray, N. K. Sewankambo, F. Wabwire-Mangen, M. Z. Chen, T. C. Quinn, T. Lutalo, N. Kiwanuka, G. Kigozi, F. Nalugoda, M. P. Meehan, R. Ashley Morrow, and M. J. Wawer. 2003. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J. Infect. Dis. 188:1492-1497.
27. Smith, J. S., and N. J. Robinson. 2002. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J. Infect. Dis. 186(Suppl. 1):S3-S28.
28. Su, H. K., J. D. Fetherston, M. E. Smith, and R. J. Courtney. 1993. Orientation of the cleavage site of the herpes simplex virus glycoprotein G-2. J. Virol. 67:2954-2959.
29. Svennerholm, B., S. Olofsson, S. Jeansson, A. Vahlne, and E. Lycke. 1984. Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J. Clin. Microbiol. 19:235-239.
30. Tunback, P., T. Bergstrom, G. B. Lowhagen, J. Hoebeke, and J. A. Liljeqvist. 2005. Type-specific reactivity of anti-glycoprotein G antibodies from herpes simplex virus-infected individuals is maintained by single or dual type-specific residues. J. Gen. Virol. 86:247-251.
31. Tunback, P., J. A. Liljeqvist, G. B. Lowhagen, and T. Bergstrom. 2000. Glycoprotein G of herpes simplex virus type 1: identification of type-specific epitopes by human antibodies. J. Gen. Virol. 81:1033-1040.
32. Van Dyck, E., A. Buvé, H. A. Weiss, J. R. Glynn, D. W. G. Brown, B. De Deken, J. Parry, and R. J. Hayes. 2004. Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J. Clin. Microbiol. 42:2961-2965.
33. Wald, A. 2004. Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes 11(Suppl. 3):130A-137A.
34. Wald, A., and K. Link. 2002. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J. Infect. Dis. 185:45-52.
35. Wald, A., J. Zeh, S. Selke, T. Warren, A. J. Ryncarz, R. Ashley, J. N. Krieger, and L. Corey. 2000. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N. Engl. J. Med. 342:844-850.
36. Zweig, M. H., and G. Campbell. 1993. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39:561-577.